Federal award (DELIVERY ORDER, fiscal year 2024)
Recipient: AMERISOURCEBERGEN DRUG CORP
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2024-12-30 to 2024-12-31
Current total value of award: $8935.43
Description: 4566809274!QUILLIVANT XR ORAL SUSP 60ML 5MG/ML